APP and familial Alzheimer disease: In addition to triggering synaptic and tau pathology chronic administration of glucocorticoids exacerbates amyloid pathology, with accelerated amyloid deposition and cognitive deficits in transgenic mice overexpressing amyloid precursor protein (APP) with familial Alzheimer’s disease mutations [16].